Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherri M Donat

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Urology|May 11, 2010
Editorial commentSherri M Donat
BJU International|August 17, 2010
Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopyHarry W Herr, Sherri M Donat
European Urology|April 19, 2011
Bacillus Calmette-Guérin without maintenance therapy for high-risk non-muscle-invasive bladder cancerHarry W Herr, Guido Dalbagni, Sherri M Donat
The Journal of Urology|September 8, 2025
Reply by AuthorsSherri M Donat, Amy L Tin, Andrew J Vickers, et al.
The Journal of Urology|September 8, 2025
Reply by AuthorsSherri M Donat, Amy L Tin, Andrew J Vickers, et al.
The Journal of Urology|August 6, 2025
"Neoadjuvant Chemotherapy with Transurethral Resection for Bladder Preservation: 15-year follow-up of the retained bladder"Sherri M Donat, Amy L Tin, Andrew J Vickers, et al.
The Journal of Urology|November 26, 2020
Intraoperative Ureteral Stent Use at Radical Cystectomy is Associated with Higher 30-Day Complication RatesSherri M Donat, Kay See Tan, Ghalib Jibara, et al.
The Journal of Urology|May 14, 2013
Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failureItay A Sternberg, Guido Dalbagni, Ling Y Chen, et al.
BJU International|September 29, 2011
Assessment of complication and functional outcome reporting in the minimally invasive prostatectomy literature from 2006 to the presentA Ari Hakimi, David M Faleck, Steven Sobey, et al.
The Journal of Urology|March 27, 2007
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancerGanesh V Raj, Harry Herr, Angel M Serio, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Urology|May 11, 2010
Editorial commentSherri M Donat
BJU International|August 17, 2010
Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopyHarry W Herr, Sherri M Donat
European Urology|April 19, 2011
Bacillus Calmette-Guérin without maintenance therapy for high-risk non-muscle-invasive bladder cancerHarry W Herr, Guido Dalbagni, Sherri M Donat
The Journal of Urology|September 8, 2025
Reply by AuthorsSherri M Donat, Amy L Tin, Andrew J Vickers, et al.
The Journal of Urology|September 8, 2025
Reply by AuthorsSherri M Donat, Amy L Tin, Andrew J Vickers, et al.
The Journal of Urology|August 6, 2025
"Neoadjuvant Chemotherapy with Transurethral Resection for Bladder Preservation: 15-year follow-up of the retained bladder"Sherri M Donat, Amy L Tin, Andrew J Vickers, et al.
The Journal of Urology|November 26, 2020
Intraoperative Ureteral Stent Use at Radical Cystectomy is Associated with Higher 30-Day Complication RatesSherri M Donat, Kay See Tan, Ghalib Jibara, et al.
The Journal of Urology|May 14, 2013
Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guérin treatment failureItay A Sternberg, Guido Dalbagni, Ling Y Chen, et al.
BJU International|September 29, 2011
Assessment of complication and functional outcome reporting in the minimally invasive prostatectomy literature from 2006 to the presentA Ari Hakimi, David M Faleck, Steven Sobey, et al.
The Journal of Urology|March 27, 2007
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancerGanesh V Raj, Harry Herr, Angel M Serio, et al.
Pageof 3